With these Wirecutter-approved picks under $100, you don’t have to spend a lot to get a good deal this Amazon Prime Day.

A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has been shown to be more effective at improving progression-free survival than Bristol-Myers Squibb's immunotherapy ...

Immatics has become the latest partner for GSK in the area of cell therapy for cancer to see its alliance shelved, just two and a half years after being set up.